Immunoglobulin kappa variable 1-6 (IGKV1-6)

Immunoglobulin kappa variable 1-6 (IGKV1-6) is a variable (V) region of the immunoglobulin kappa light chain, contributing to the antigen-binding domain of antibodies (immunoglobulins)[1][6][9]. It is involved in antigen recognition as part of the humoral immune response. The V region pairs with the variable domain of a heavy chain to form the antigen-binding site of an antibody[1][4][6][9]. This region is generated through a process called V-(D)-J recombination and undergoes somatic hypermutation to promote antibody diversity and affinity maturation after exposure to antigens[1][6]. IGKV1-6 does not itself serve as a direct therapeutic target, receptor, enzyme, transporter, or clinically actionable biomarker, but is a genomic and protein segment crucial for antibody diversity and function[1][4][9]. Notes: - There is no evidence in the literature that IGKV1-6 is a therapeutic target (such as a druggable receptor, enzyme, etc.)[1][4][9]. - The alias “L11” is also used for a ribosomal protein, but within the IGKV1-6 context, it refers to an immunoglobulin gene segment[1][8]. - No drugs interact directly with IGKV1-6, nor does it serve as a recognized biomarker or carry safety concerns as an individual target. - It is mainly important in basic immunology for understanding antibody gene structure, recombination, and the basis of antigen recognition in humoral immunity[1][4][6][9].

Other names

IGKV16L11KV106Immunoglobulin kappa variable region 1-6